StockNews.AI
REPL
StockNews.AI
14 days

Lost Money on Replimune Group, Inc.(REPL)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

1. Replimune Group faces a class action lawsuit for alleged securities fraud. 2. The lawsuit claims false statements about IGNYTE trial effectiveness affected investors. 3. Investors have until September 22, 2025, to join the class action. 4. No out-of-pocket costs for class members participating in the lawsuit. 5. Levi & Korsinsky has a strong track record in securities litigation.

5m saved
Insight
Article

FAQ

Why Bearish?

Class action lawsuits often lead to stock price declines. Historical cases show negative investor sentiment impacting stock value.

How important is it?

The class action lawsuit directly affects investor perceptions, impacting REPL's stock price.

Why Short Term?

The lawsuit's news may generate immediate negative market reactions. Similar previous lawsuits have influenced short-term prices adversely.

Related Companies

AMGNBMY
, /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. ("Replimune Group, Inc." or the "Company") (NASDAQ: REPL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Replimune Group, Inc. investors who were adversely affected by alleged securities fraud between November 22, 2024 and July 21, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/replimune-group-inc-lawsuit-submission-form?prid=159022&wire=4 REPL investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) defendants recklessly overstated the IGNYTE trial's prospects, given material issues that defendants knew or should have known of, which resulted in the FDA deeming the IGNYTE trial inadequate and not well-controlled; and (2) as a result, defendants' statements about Replimune's business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. WHAT'S NEXT? If you suffered a loss in Replimune Group, Inc. during the relevant time frame, you have until September 22, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. CONTACT:Levi & Korsinsky, LLP Joseph E. Levi, Esq.Ed Korsinsky, Esq.33 Whitehall Street, 17th FloorNew York, NY 10004[email protected]Tel: (212) 363-7500Fax: (212) 363-7171www.zlk.com SOURCE Levi & Korsinsky, LLP WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News